CN106580911A - 一种空心胶囊及其制备方法 - Google Patents
一种空心胶囊及其制备方法 Download PDFInfo
- Publication number
- CN106580911A CN106580911A CN201611084923.5A CN201611084923A CN106580911A CN 106580911 A CN106580911 A CN 106580911A CN 201611084923 A CN201611084923 A CN 201611084923A CN 106580911 A CN106580911 A CN 106580911A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- ganoderma
- capsuleses
- green tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 55
- 239000000843 powder Substances 0.000 claims abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 17
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 17
- 241001076416 Dendrobium tosaense Species 0.000 claims abstract description 17
- 241000222336 Ganoderma Species 0.000 claims description 38
- 244000269722 Thea sinensis Species 0.000 claims description 26
- 235000009569 green tea Nutrition 0.000 claims description 23
- 239000003292 glue Substances 0.000 claims description 22
- 239000000576 food coloring agent Substances 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000007493 shaping process Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 7
- 235000013305 food Nutrition 0.000 abstract description 7
- 240000008397 Ganoderma lucidum Species 0.000 abstract description 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 abstract 3
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 abstract 3
- 229940030275 epigallocatechin gallate Drugs 0.000 abstract 3
- 108010010803 Gelatin Proteins 0.000 abstract 2
- 229920000159 gelatin Polymers 0.000 abstract 2
- 239000008273 gelatin Substances 0.000 abstract 2
- 235000019322 gelatine Nutrition 0.000 abstract 2
- 235000011852 gelatine desserts Nutrition 0.000 abstract 2
- 235000011187 glycerol Nutrition 0.000 abstract 2
- 239000000049 pigment Substances 0.000 abstract 1
- 239000008213 purified water Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 108010025899 gelatin film Proteins 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 206010061192 Haemorrhagic fever Diseases 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229930182483 coumarin glycoside Natural products 0.000 description 1
- 150000008140 coumarin glycosides Chemical class 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- -1 triterpeness Natural products 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种空心胶囊,包括如下重量份制成:铁皮石斛粉10‑20份,灵芝粉5‑10份,绿茶素5‑10份,食用明胶10‑20份,甘油5‑15份,食用色素柠檬黄1‑10份,纯净水10‑60份。本发明还公开了一种空心胶囊制备方法。本发明提供的空心胶囊具有铁皮石斛、灵芝、绿茶素保健成分与食用明胶、药用甘油各自的功效集于一体,在空心胶囊填入其他保健食品、药品,使普通人群在食用一种食品或药品时,能够方便地摄入铁皮石斛、灵芝、绿茶素对人体有益的成分。
Description
技术领域
本发明属于食品领域,尤其是一种空心胶囊及其制备方法。
背景技术
空心胶囊主要用于制药行业,用于盛装固体药物,如自制散剂、保健品、药剂等,空心胶囊为服用者解决了难入口、口感差的不足之处。空心胶囊由食用明胶加辅料精制而成。食用明胶在许多食品中被广泛应用,如布丁、甜食、蜜饯、咀嚼式糖果、糖衣、食物罐头以及蘸料。在食品中,食用明胶能够帮助食物凝固、变稠、稳定、通气。食用明胶本身是从胶原质中提取的一种水溶性蛋白质,而胶原质是结缔组织中主要的天然蛋白质成分。食用明胶是通过一个受控的提取过程,从动物的皮肤和骨骼中得到。空心胶囊制作时用模具上形成一层明胶薄膜,然后明胶薄膜变干硬化,形成胶囊。一般有两种尺寸的模具,一种用来制作胶囊体,另一种直径较大的用来制作胶囊帽。
目前,以铁皮石斛、灵芝、绿茶素为主要成分的空心胶囊尚未有报道。
发明内容
本发明目的是提供一种具有保健作用的空心胶囊其制备方法。
技术方案:一种空心胶囊包括如下重量份制成:铁皮石斛粉10-20份,灵芝粉5-10份,绿茶素5-10份,食用明胶10-20份,甘油5-15份,食用色素柠檬黄1-10份,纯净水10-60份。
优选地,一种空心胶囊包括如下重量份制成:铁皮石斛粉10份,灵芝粉5份,绿茶素5份,食用明胶10份,甘油5份,食用色素柠檬黄1份,纯净水10份。
优选地,一种空心胶囊包括如下重量份制成:铁皮石斛粉20份,灵芝粉10份,绿茶素10份,食用明胶20份,甘油15份,食用色素柠檬黄10份,纯净水60份。
优选地,一种空心胶囊包括如下重量份制成:铁皮石斛粉15份,灵芝粉8份,绿茶素7份,食用明胶15份,甘油10份,食用色素柠檬黄5份,纯净水40份。
一种空心胶囊的制备方法包括如下:
(1)将300-400目筛的灵芝粉、食用明胶、甘油、食用色素柠檬黄混合,加入纯净水,搅拌均匀后,50-90℃加热溶胶,糊化1小时,得到灵芝胶液;
(2)将灵芝胶液煮至110—120℃,20分钟;
(3)将煮好的灵芝胶液冷却至70-80℃,加入300-400目筛的铁皮石斛粉,300-350目筛的绿茶素,搅拌均匀,置于60℃的恒温蘸胶箱,在模具上冷却成型;
(4)将胶囊坯置于30℃的鼓风干燥箱中脱水干燥0.6-1小时后,脱模切割;经切割、套合、灭菌。
上述物料按比例加入。
有益效果:本发明提供的空心胶囊具有铁皮石斛、灵芝、绿茶素保健成分与食用明胶、甘油各自的功效集于一体,空心胶囊填入其他保健食品、药品,使普通人群或者体质虚弱者在食用一种食品或药品时,能够方便地摄入铁皮石斛、灵芝、绿茶素对人体有益的成分,是一种具有功能性的保健食品。
铁皮石斛(学名:Dendrobium officinale Kimura et Migo):茎直立,圆柱形,长9-35厘米,粗2-4毫米,不分枝,具多节;叶二列,纸质,长圆状披针形,边缘常带淡紫色。铁皮石斛具有生津作用,主要表现为促进腺体分泌和脏器运动。还具有降血糖作用、增强机体免疫力效果,对非特异性免疫功能,或是特异性细胞免疫以及体液免疫功能,均有一定的提高作用。
灵芝(学名:Ganoderma Lucidum Karst)是多孔菌科真菌灵芝的子实体。具有补气安神、止咳平喘、延年益寿的功效。主含氨基酸、多肽、蛋白质、真菌溶菌酶,以及糖类(还原糖和多糖)、麦角甾醇、三萜类、香豆精甙、挥发油、硬脂酸、苯甲酸、生物碱、维生素B2等;孢子还含甘露醇、海藻糖。灵芝药用在我国已有2000多年的历史,被历代医药家视为滋补强壮、扶正固本的神奇珍品。经过大量临床研究,灵芝对神经衰弱、高脂血症、冠心病心绞痛、心律失常、克山病、高原不适症、肝炎、出血热、消化不良、气管炎等各有不同程度的疗效。
绿茶素又叫茶多酚(tea polyphenol,TP),是儿茶素、花青素、黄酮与黄酮类等集于绿茶中的一种多酚复合物及其衍生物的总称,以绿茶为原料,易溶于水,可以直接被细胞吸收,是人体内调控基因和预防疾病的有效物质,在人体内起到修复受损细胞、提高细胞代谢功能、激活休眠细胞的作用。研究证实:绿茶素具有很强的消除有害自由基的作用;抗衰老作用;降血脂、降血压、降血糖、调节胆固醇的作用;抑制肿瘤细胞生长;此外,茶多酚还具有止泻、利尿、防治坏血病等作用。
具体实施方式
实施例1:一种空心胶囊包括如下重量份制成:铁皮石斛粉10份,灵芝粉5份,绿茶素5份,食用明胶10份,甘油5份,食用色素柠檬黄1份,纯净水10份。
制备方法包括如下:
(1)将300目筛的灵芝粉、食用明胶、甘油、食用色素柠檬黄混合,加入纯净水,搅拌均匀后,50℃加热溶胶,糊化1小时,得到灵芝胶液;
(2)将灵芝胶液煮至110℃,20分钟;
(3)将煮好的灵芝胶液冷却至70℃,加入300目筛的铁皮石斛粉,300目筛的绿茶素,搅拌均匀,置于60℃的恒温蘸胶箱,在模具上冷却成型;
(4)将胶囊坯置于30℃的鼓风干燥箱中脱水干燥0.6小时后,脱模切割;经切割、套合、灭菌。
上述物料按比例加入。
实施例2:一种空心胶囊包括如下重量份制成:铁皮石斛粉20份,灵芝粉10份,绿茶素10份,食用明胶20份,甘油15份,食用色素柠檬黄10份,纯净水60份。
制备方法包括如下:
(1)将300-400目筛的灵芝粉、食用明胶、甘油、食用色素柠檬黄混合,加入纯净水,搅拌均匀后,90℃加热溶胶,糊化1小时,得到灵芝胶液;
(2)将灵芝胶液煮至120℃,20分钟;
(3)将煮好的灵芝胶液冷却至80℃,加入400目筛的铁皮石斛粉,350目筛的绿茶素,搅拌均匀,置于60℃的恒温蘸胶箱,在模具上冷却成型;
(4)将胶囊坯置于30℃的鼓风干燥箱中脱水干燥1小时后,脱模切割;经切割、套合、灭菌。
上述物料按比例加入。
实施例3:一种空心胶囊包括如下重量份制成:铁皮石斛粉15份,灵芝粉8份,绿茶素7份,食用明胶15份,甘油10份,食用色素柠檬黄5份,纯净水40份。
制备方法包括如下:
(1)将350目筛的灵芝粉、食用明胶、甘油、食用色素柠檬黄混合,加入纯净水,搅拌均匀后,70℃加热溶胶,糊化1小时,得到灵芝胶液;
(2)将灵芝胶液煮至115℃,20分钟;
(3)将煮好的灵芝胶液冷却至75℃,加入350目筛的铁皮石斛粉,330目筛的绿茶素,搅拌均匀,置于60℃的恒温蘸胶箱,在模具上冷却成型;
(4)将胶囊坯置于30℃的鼓风干燥箱中脱水干燥0.8小时后,脱模切割;经切割、套合、灭菌。
上述物料按比例加入。
Claims (5)
1.一种空心胶囊,其特征在于包括如下重量份制成:铁皮石斛粉10-20份,灵芝粉5-10份,绿茶素5-10份,食用明胶10-20份,甘油5-15份,食用色素柠檬黄1-10份,纯净水10-60份。
2.根据权利要求1所述的一种空心胶囊的,其特征在于包括如下重量份制成:铁皮石斛粉10份,灵芝粉5份,绿茶素5份,食用明胶10份,甘油5份,食用色素柠檬黄1份,纯净水10份。
3.根据权利要求1所述的一种空心胶囊的,其特征在于包括如下重量份制成:铁皮石斛粉20份,灵芝粉10份,绿茶素10份,食用明胶20份,甘油15份,食用色素柠檬黄10份,纯净水60份。
4.根据权利要求1所述的一种空心胶囊的,其特征在于包括如下重量份制成:铁皮石斛粉15份,灵芝粉8份,绿茶素7份,食用明胶15份,甘油10份,食用色素柠檬黄5份,纯净水40份。
5.根据权利要求1所述的一种空心胶囊的制备方法,其特征在于包括如下方法:
(1)将300-400目筛的灵芝粉,食用明胶,甘油,食用色素柠檬黄混合,加入纯净水,搅拌均匀后,50-90℃加热溶胶,糊化1小时,得到灵芝胶液,
(2)将灵芝胶液煮至110—120℃,20分钟;
(3)将煮好的灵芝胶液冷却至70-80℃,加入300-400目筛的铁皮石斛粉,300-350目筛的绿茶素,搅拌均匀,置于60℃的恒温蘸胶箱,在模具上冷却成型;
(4)将胶囊坯置于30℃的鼓风干燥箱中脱水干燥0.6-1小时后,脱模切割;经切割、套合、灭菌;
上述物料按比例加入。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611084923.5A CN106580911A (zh) | 2016-11-30 | 2016-11-30 | 一种空心胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611084923.5A CN106580911A (zh) | 2016-11-30 | 2016-11-30 | 一种空心胶囊及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106580911A true CN106580911A (zh) | 2017-04-26 |
Family
ID=58594461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611084923.5A Pending CN106580911A (zh) | 2016-11-30 | 2016-11-30 | 一种空心胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106580911A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111686090A (zh) * | 2020-06-17 | 2020-09-22 | 福建省神六保健食品有限公司 | 一种螺旋藻灵芝孢子油软胶囊及其加工工艺 |
CN112586726A (zh) * | 2020-12-03 | 2021-04-02 | 青岛大学附属医院 | 一种最大限度保留生物活性的壮阳食品制备方法 |
CN114514956A (zh) * | 2020-11-19 | 2022-05-20 | 河北科星药业有限公司 | 用于辅助喂食宠物药物的凝胶空心糖果、其制备方法及应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105919073A (zh) * | 2016-04-25 | 2016-09-07 | 孙继勇 | 一种用破壁灵芝孢子粉制作的空心植物胶囊及其制作方法 |
-
2016
- 2016-11-30 CN CN201611084923.5A patent/CN106580911A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105919073A (zh) * | 2016-04-25 | 2016-09-07 | 孙继勇 | 一种用破壁灵芝孢子粉制作的空心植物胶囊及其制作方法 |
Non-Patent Citations (1)
Title |
---|
东方: "保健食品各剂型的概念、特点及制作方法", 《江苏食品与发酵》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111686090A (zh) * | 2020-06-17 | 2020-09-22 | 福建省神六保健食品有限公司 | 一种螺旋藻灵芝孢子油软胶囊及其加工工艺 |
CN114514956A (zh) * | 2020-11-19 | 2022-05-20 | 河北科星药业有限公司 | 用于辅助喂食宠物药物的凝胶空心糖果、其制备方法及应用 |
CN112586726A (zh) * | 2020-12-03 | 2021-04-02 | 青岛大学附属医院 | 一种最大限度保留生物活性的壮阳食品制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103355592A (zh) | 一种保健面条 | |
CN106580911A (zh) | 一种空心胶囊及其制备方法 | |
CN104664005A (zh) | 一种航天员专用的巧克力及其制作方法 | |
CN103431011A (zh) | 艾橘杏仁保健饼干 | |
CN102277286B (zh) | 一种保健药酒、养生禽蛋制品及其制造方法 | |
CN102550738A (zh) | 一种可防辐射、提高免疫力的保健茶及其制备方法 | |
CN103892475B (zh) | 保健文胸 | |
CN104383412A (zh) | 解郁养生中药酒及制备方法 | |
CN110551586A (zh) | 一种大鲵蛋白肽养生酒及其酿造方法 | |
CN103039901B (zh) | 一种化湿和中的藕粉及制备方法 | |
CN104351598A (zh) | 一种具有降血脂作用的果冻 | |
CN106819962A (zh) | 一种余甘子食品及其制备方法 | |
CN106617083A (zh) | 一种灵芝绿茶空心胶囊及其制备方法 | |
CN104905159B (zh) | 一种百合茶油风味豆豉及其加工方法 | |
CN106580910A (zh) | 一种桃金娘果食品及其制备方法 | |
CN107751989A (zh) | 一种保健食品组合物及其制备方法 | |
CN106722940A (zh) | 一种食品及其制备方法 | |
KR101375347B1 (ko) | 홍삼약초 음료의 제조방법 및 상기 방법으로 제조된 홍삼 음료 | |
KR101093006B1 (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 | |
CN103461821B (zh) | 一种黑茶膏代替食用胶生产面条的加工方法 | |
CN103461769A (zh) | 一种三七面粉的制作方法 | |
CN106819843A (zh) | 一种燕麦食品及其制备方法 | |
CN108522724A (zh) | 一种富硒保健白茶及其加工方法 | |
CN102813760A (zh) | 一种具有降血脂功能的天然药食同源原料组成及制备方法 | |
CN106722939A (zh) | 一种莲子食品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170426 |
|
RJ01 | Rejection of invention patent application after publication |